title: Metastatic brain tumors: current therapeutic options and historical perspective.
abstract: Metastatic brain tumors affect more than 150,000 patients annually in the United States. The therapeutic paradigms for these tumors have evolved over the years and currently encompass numerous modalities implemented by treating physicians across several medical disciplines. The armamentarium of brain tumor treatment involves neurosurgical intervention, whole-brain and focused radiation modalities, chemotherapy, and immunotherapy. Patient selection, however, remains critical to achieve maximal therapeutic benefit and depends on functional status, number and location of lesions, and tissue histologic findings. Best outcomes can be expected with a multidisciplinary approach to patient care where state-of-the-art treatment options are readily available.
authors.affiliation: Department of Neurosurgery, Philadelphia College of Osteopathic Medicine, Pennsylvania, USA. mrivkin@charter.net
authors.forename: Mark
authors.initials: M
authors.lastname: Rivkin
authors.forename: Richard B
authors.initials: RB
authors.lastname: Kanoff
mesh_terms: D001932:Brain Neoplasms / Q000453:epidemiology / Q000556:secondary / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D015995:Prevalence; D015996:Survival Rate / Q000639:trends; D014481:United States / Q000453:epidemiology